Clean Power Hydrogen Plc

Report Publication Announcement • May 21, 2025

National Storage Mechanism | Additional information

RNS Number : 2703J

Clean Power Hydrogen

21 May 2025

21 May 2025

Clean Power Hydrogen plc

("CPH2", the "Company" or the "Group")

Posting of Annual Report and Notice of Annual General Meeting

CPH2, the UK-based green hydrogen technology and manufacturing company that has developed the IP-protected Membrane-Free Electrolyser ("MFE"), announces that the Company's 2025 Annual General Meeting ("AGM") will be held at Doncaster Racecourse, The Royal Suite, Bawtry Road, Doncaster, DN2 6BB at 11:00am on 19 June 2025. The Notice of AGM has been posted to shareholders and is available on the Company's website at  https://www.cph2.com/investors/circulars-documents/ .

The Company's 2024 Annual Report, has also been posted to shareholders and is available on the Company's website at  www.cph2.com/investors/results-reports-presentations/ .

.

ENDS

For more information, please contact:

Clean Power Hydrogen plc	via Camarco
Jon Duffy, Chief Executive Officer
James Hobson, Chief Financial Officer
Cavendish Capital Markets Limited - NOMAD & Broker
Neil McDonald	+44 (0)131 220 9771
Peter Lynch	+44 (0)131 220 9772
Adam Rae	+44 (0)131 220 9778
Camarco PR	+ 44(0) 20 3 757 4980
Owen Roberts
Kirsty Duff

To find out more, please visit: https://www.cph2.com

Overview of CPH2

CPH2 is the holding company of Clean Power Hydrogen Group Limited which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. CPH2 is listed on the AIM market and trades under the ticker LON:CPH2.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOAPKCBQQBKDQPD